Cannabics Pharmaceuticals Inc (CNBX) 0.0509

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cannabics Pharmaceuticals Inc (CNBX) 0.0509 $CNBX

Cannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System
PR Newswire - Mon Jun 06, 10:07AM CDT
Cannabics Pharmaceuticals Inc. (CNBX) filed a PCT Application with the US Patent & Trademark Office (USPTO) entitled a "System and Method for High Throughput Screening of Cancer Cells".

Cannabics Pharmaceuticals Announces Start of Clinical Study in Israel for Cancer Patients
PR Newswire - Tue Mar 22, 9:00AM CDT
Cannabics Pharmaceuticals Inc. (CNBX) today announced the start of a clinical study in Israel for cancer patients utilizing Cannabics' SR Capsules. This is one of the world's first clinical studies specifically examining the effect of cannabis utilizing a medically standardized edible delivery system.

Cannabics Pharmaceuticals Inc. Announces a New Division of Labor in the Corporate Structure
PR Newswire - Fri Oct 09, 8:00AM CDT
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) has announced its execution of an Intellectual Property & Subsidiary Assignment and an Assignment & Assumption of Debt & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, related party, and a majority holder of 88% of the company.

North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 0.85 (+0.02), INSY: 15.66 (+0.02), ARNA: 1.69 (+0.01)

DigiPath Labs Clears the Way for Las Vegas' First Cannabis Dispensary
ACCESSWIRE - Fri Aug 21, 11:56AM CDT
SEATTLE, WA / ACCESSWIRE / August 21, 2015 / Nevada legalized medical marijuana in 2001, enabling patients to grow a maximum of 12 cannabis plants at home, but the first dispensary in Southern Nevada selling medical marijuana to the public opened just this month with the passing of Senate Bill 374. The bill clears the way for up to 66 dispensaries and 200 production facilities to operate in the Silver State under the direction of the Department of Health and Human Services.

Cannabics Pharmaceuticals Inc. Announces Increasing Sales of WanaCapsXR Capsules in Every Region of Colorado
PR Newswire - Thu Aug 13, 8:30AM CDT
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that first reports from Colorado show that WanaCapsXR cannabis capsules are sold in every region of Colorado.

Cannabics Pharmaceuticals Inc. Engages with the Technion Institute for Screening of Potential Anticancer Cannabinoid Compounds
ACCESSWIRE - Thu Apr 02, 6:25PM CDT
BETHESDA, MD / ACCESSWIRE / April 2, 2015 / Cannabics Pharmaceuticals Inc. (OTCQB:CNBX) announced today that it has executed a Research Agreement with the Israel Institute of Technology (Technion) in Israel, for the screening of potential Anticancer Cannabinoid compounds.

Anorexia Nervosa Global Clinical Trials Review, H1, 2015
M2 - Wed Apr 01, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7tzf2t/anorexia_nervosa) has announced the addition of the "Anorexia Nervosa Global Clinical Trials Review, H1, 2015" report to their offering. Anorexia Nervosa Global Clinical Trials Review, H1, 2015 provides data on the Anorexia Nervosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anorexia Nervosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anorexia Nervosa. Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Top Companies Participating in Anorexia Nervosa Therapeutics Clinical Trials - Sky Growth Acquisition Corporation - Medionics International Inc - Daiichi Sankyo Company, Limited - Cannabics Pharmaceuticals, Inc. - Bristol-Myers Squibb Company - BioGaia AB - AstraZeneca PLC - Arjun Healthcare - Anaborex, Inc. For more information visit http://www.researchandmarkets.com/research/7t...ia_nervosa
AZN: 34.14 (-0.15), BMY: 74.65 (-0.01)

Cannabics Pharmaceuticals engages with Mountain High Products in Colorado
PR Newswire - Thu Dec 18, 8:41AM CST
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has executed a letter of engagement with Mountain High Products in Colorado, for the manufacturing and distribution of Cannabics SR medical cannabis products in the Colorado market.

Cannabics Pharmaceuticals Signs IP Licensing and Collaboration Agreement in Spain
Marketwired - Thu Nov 06, 7:32AM CST
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has executed an IP Licensing and Collaboration Agreement with Kalapa Holding (Spain) for the production and distribution of CANNABICS SR medical cannabis products in the Spanish market.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Artprice News Revolutionizes Global Art Market Information

Updated Category News Views 237

Artprice News Launch: A New Chapter in Art Market Reporting Artprice by Artmarket has introduced a groundbreaking initiative with the launch of Artprice News, marking a significant evolution in the landscape of art market information. This innovative news agency is tailored exclusively for the art world, broadcasting valuable insights in 11 languages and spanning 122...

Continue Reading
U-BX Technology Ltd. Responds to Nasdaq Notification on Listing

Updated Category News Views 211

U-BX Technology Ltd. Responds to Nasdaq Notification U-BX Technology Ltd. (NASDAQ: UBXG), recognized as a frontrunner in offering innovative services powered by artificial intelligence to the insurance sector, recently informed stakeholders regarding important notifications received from The Nasdaq Stock Market LLC. Details of Nasdaq Notification Letters On a recent date,...

Continue Reading
Understanding Investor Rights in Newmont Securities Class Action

Updated Category News Views 370

Understanding the Basics of the Newmont Class Action Investors who have sustained losses exceeding $50,000 in Newmont Corporation should take heed of an active class action. This legal effort aims to provide relief for those affected by adverse developments within the company. Faruqi & Faruqi, LLP, a prominent securities law firm, is at the forefront of this investigation...

Continue Reading
Tarte's Record-Breaking Collab: 60 Seconds to Sellout

Updated Category News Views 129

When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...

Continue Reading
What Lessons Can Traditional Investors Learn From the Rise of Ethereum?

Updated Category Crypto Views 3176

Turn the clock back a few decades, and investors on Wall Street would laugh if you tried to pitch the concept of blockchain to them. It’s one of those ideas that sound like they’d technically work but would be impossible to practically execute. Yet today, blockchain and cryptocurrency exist and are proof that the skeptics were wrong. Sadly, many traditional investors...

Continue Reading